Form 8-K - Current report:
SEC Accession No. 0001558370-24-009006
Filing Date
2024-06-07
Accepted
2024-06-07 16:06:18
Documents
15
Period of Report
2024-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20240607x8k.htm   iXBRL 8-K 72289
2 EX-10.1 nrbo-20240607xex10d1.htm EX-10.1 15778
3 GRAPHIC nrbo-20240607x8k001.jpg GRAPHIC 12152
  Complete submission text file 0001558370-24-009006.txt   248592

Data Files

Seq Description Document Type Size
4 EX-101.SCH nrbo-20240607.xsd EX-101.SCH 3145
5 EX-101.LAB nrbo-20240607_lab.xml EX-101.LAB 15925
6 EX-101.PRE nrbo-20240607_pre.xml EX-101.PRE 10068
18 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20240607x8k_htm.xml XML 4823
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 241029336
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)